Readers Sound Off on Fibromyalgia Drugs
In my previous column, “Lyrica, Cymbalta and Savella: Do They Work?” I shared research studies and my own experience with the three medications approved for use in treating fibromyalgia.
Clinical studies on all three drugs don’t seem to offer enough creditable evidence that they are effective in managing fibromyalgia symptoms. Moreover, they carry very harsh side effects, including weight gain, edema, nausea, headaches, vertigo, sleep issues, and changes in blood pressure.
My experience was similar. Lyrica, Cymbalta and Savella were ineffective for me, and had some tough and life-altering side effects.
It makes me wonder why doctors are still prescribing these medications and why the Food and Drug Administration continues to allow them to stay on the market.
In 2012, German researchers aimed to assess the benefits and harms of Cymbalta and Savella in treating fibromyalgia. Ten studies with over 6,000 fibromyalgia patients were reviewed.
The results were that 22 percent of patients reported substantial relief and 21 percent had to quit treatment due to unpleasant side effects.